Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Burning Rock, Boehringer Ingelheim Ink Master Service Agreement for Oncology Companion Diagnostics
The companies will focus initially on Boehringer Ingelheim's MDM2-p53 antagonist, brigimadlin, now being studied in a new Phase II trial in China.
Liquid Biopsy Company Precede Biosciences Emerges From Stealth With $57M in Financing
The firm's technology detects genome-wide patterns of gene activation, promotion, and methylation in circulating chromatin from a 1-mL plasma sample.
Centogene Regains Compliance With Nasdaq Listing Requirements
The company had already regained compliance with Nasdaq's requirements once before this year, after missing the minimum bid price requirement last December.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.